Guest guest Posted October 12, 2011 Report Share Posted October 12, 2011 Inovio inks licensing deal for hep B and C vaccines in Asia with VGX International Proactive Investors USA & Canada Inovio Pharmaceuticals (AMEX:INO) said Monday it has entered into a product development agreement with affiliate VGX International, to co-develop Inovio's SynCon therapeutic vaccines for hepatitis B and C infections. Under the terms of the deal, ... Dynavax jumps on new hepatitis B vaccine data BusinessWeek Dynavax Technologies Corp. said Monday that testing shows its hepatitis B vaccine Heplisav works better on hard-to-treat patients than an older vaccine. The company said men, smokers, and people who are obese do not respond as well to hepatitis B ... Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.